Schiff Assists Biofrontera with $18M IPO
Schiff Hardin LLP represented the underwriters in Biofrontera Inc.’s $18 million initial public offering of 3,600,000 units.
Schiff Hardin LLP represented the underwriters in Biofrontera Inc.’s $18 million initial public offering of 3,600,000 units. Biofrontera is a biopharmaceutical company specializing in the commercialization of dermatological products. Roth Capital Partners and The Benchmark Company acted as the joint book-running managers for the offering, which closed on Nov. 2, 2021.
Smart In Your World
Your goals define our mission. Whether an immediate need or a long-term objective, ArentFox Schiff helps you reach your full potential. As industry insiders, we partner with you to develop practical business strategies and sophisticated legal solutions to achieve today’s targets and anticipate tomorrow’s problems. We get you across the finish line.
Contacts
-
Contact:
Nathan Carlile, Head of Firmwide Communications
- Related Practices